Wednesday, June 10, 2026

pharma Β· Nonalcoholic Steatohepatitis (NASH) Β· Amyotrophic Lateral Sclerosis Β· CORT

CORCEPT THERAPEUTICS

CORCEPT THERAPEUTICS clinical programs β€” 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

101 Redwood Shores Pkwy, Redwood City, California 94065, US HQ
1998 Founded
756 Employees
Public company Type
CORT Β· NYSE Ticker
Company details
Status
Public
HQ
101 Redwood Shores Pkwy, Redwood City, California 94065, US
Founded
1998
Employees
756
Programs
67
Drugs
36
Patents
120
Intelligence Β· Clinical Programs

CORCEPT THERAPEUTICS projects

11 ClinicalTrials.gov programs sponsored by CORCEPT THERAPEUTICS.

CORCEPT THERAPEUTICS has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CORT125134-452

    CORCEPT THERAPEUTICS INC

    Endogenous Cushing Syndrome

    phase 3 other active

    1 trial
  2. CORT125134-556

    CORCEPT THERAPEUTICS INC

    Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

    phase 3 small molecule active

    1 trial
  3. Mifepristone

    CORCEPT THERAPEUTICS INC

    Depressive Disorder, Major

    phase 3 small molecule completed

    1 trial
  4. Nab-paclitaxel 80 mg/m^2

    CORCEPT THERAPEUTICS INC

    Ovarian Neoplasm

    phase 3 small molecule active

    1 trial
  5. Relacorilant

    CORCEPT THERAPEUTICS INC

    Hypercortisolism

    phase 3 small molecule completed

    1 trial
  6. Relacorilant, 100 mg and 25 mg

    CORCEPT THERAPEUTICS INC

    Metastatic Pancreatic Ductal Adenocarcinoma

    phase 3 small molecule terminated

    1 trial
  7. mifepristone

    CORCEPT THERAPEUTICS INC

    Cushing's Syndrome

    phase 3 small molecule completed

    2 trials
  8. mifepristone

    CORCEPT THERAPEUTICS INC

    Cushing's Disease

    phase 3 small molecule terminated

    2 trials
  9. mifepristone

    CORCEPT THERAPEUTICS INC

    Major Depressive Disorder

    phase 3 small molecule completed

    5 trials
  10. mifepristone

    CORCEPT THERAPEUTICS INC

    Psychotic Depression

    phase 3 small molecule terminated

    1 trial
  11. relacorilant

    CORCEPT THERAPEUTICS INC

    Cushing Syndrome

    phase 3 small molecule active

    2 trials

Frequently asked questions

How many clinical projects does CORCEPT THERAPEUTICS have?

11 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.